Trevena, Inc (TRVN) - Sotuvning sof marjinal rentabelligi

Ommaviy kompaniya Trevena Inc. (TRVN) logotipi

Trevena, Inc. (TRVN) noyob terapiya usullarini ishlab chiqmoqda va makroiqtisodiy tendentsiyalardan mustaqil bo'lgan suveren mahsulot siklini yaratmoqda. Sof foyda marjasi ushbu progressni aks ettiradi, bunda 0.00 ushbu baholash parametrini tavsiflaydi. Barqarorlik shifoxona analgetiklariga bo'lgan doimiy, sikllardan tashqari talab bilan ta'minlanadi. Biznes asosi FDA bosqichlariga bog'langan aksiyalar opsionlari bilan rag'batlantirilgan yuqori darajali neyrofarmakologlardan iborat.

TRVN: trevena.com Kompaniya sotuv marjasi 04.07.2022 - 19.10.2024

Trevena, Inc. (TRVN) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Fundamental baholash:Trevena, Inc.
Trevena Inc ishlab chiqargan mahsulot

Sotuv marjalari daromadning har bir dollari ichidagi sof foyda ulushini belgilab, biznesning umumiy samaradorligini xarakterlaydi. Ushbu metrika yakuniy moliyaviy natijaning umumiy daromadga nisbati sifatida hisoblanadi va operatsion xarajatlarga bo'lgan sezgirlikni namoyish etadi. Sotuvlarning sof rentabelligi darajasini tahlil qilish kompaniyaning bozor tebranishlariga chidamliligini baholash imkonini beradi. Trevena, Inc. (TRVN) uchun ushbu metrika Olinvyk preparatini analgetik bozoriga olib chiqish xarajatlarini aks ettiradi. Opioid alternativlarini ishlab chiqishga yo'naltirilgan yuqori investitsiyalar vaqtincha rentabellikni pasaytirmoqda.

Muhim raqobatchilar

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Jupiter Neurosciences Inc (JUNS) - Sof marja|Relmada Therapeutics - Sof foyda normasi|ANVS (Annovis Bio Inc) - Sotuvning sof marjinal rentabelligi|GRCE: Sof foyda normasi|Sof marja Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Sof foyda normasi|Sof marja neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Sof marja|MTVA: Sof foyda bo'yicha sotuv rentabelligi|NeurAxis, Inc (NRXS) - Sof foyda bo'yicha sotuv rentabelligi|HSDT: Sotuvning sof marjinal rentabelligi|PASG - Kompaniya sotuv marjasi|Sof marja Neuphoria Therapeutics, Inc.|Sof marja NERV|Sotuvning sof marjinal rentabelligi ATHA|ADXN (Addex Therapeutics Ltd) - Sof foyda normasi|Sof marja alzamend.com ALZN|Kompaniya sotuv marjasi Cyclerion Therapeutics (CYCN)|Protagenic - Sotuvning sof marjinal rentabelligi|Sof foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Sotuvning sof marjinal rentabelligi|Avenue Therapeutics Inc. (ATXI) - Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Cara Therapeutics Inc|Sof marja Chromocell Therapeutics (CHRO)|Kompaniyaning sof rentabelligi ELYM|Sof marja Intra-Cellular ITCI|LBPH: Sotuvning sof rentabelligi|MRNS - Sof marja|NKGen Biotech, Inc. (NKGN) - Sof foyda bo'yicha sotuv rentabelligi|neurobopharma.com (NRBO) - Sof marja|SAGE: Kompaniyaning sof rentabelligi|Sof marja Synaptogenix, Inc.|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel